Evofem Biosciences Inc. buy krebskrebs
Start price
22.03.21
/
50%
€34.73
Target price
22.03.22
€52.50
Performance (%)
-84.26%
End price
23.03.22
€5.47
Summary
This prediction ended on 23.03.22 with a price of €5.47. The BUY prediction by krebskrebs for Evofem Biosciences Inc. performed very badly with a performance of -84.26%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evofem Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% | 52.377% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% | 72.449% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% | 57.579% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% | 62.154% |
Comments by krebskrebs for this prediction
In the thread Evofem Biosciences diskutieren
In the thread Trading Evofem Biosciences
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten